advertisement
Science News
from research organizations

Repeated infections associated with increased risk of some neurodegenerative diseases

People with hospital-treated infections in early- and mid-life had the greatest risk of Alzheimer's and Parkinson's diseases later in life

Date:
September 15, 2022
Source:
PLOS
Summary:
Infections treated with specialty hospital care in early- and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), but not amyotrophic lateral sclerosis (ALS), according to a new study.
Share:
advertisement

FULL STORY

Infections treated with specialty hospital care in early- and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), but not amyotrophic lateral sclerosis (ALS), according to a new study publishing September 15thin the open-access journalPLOS Medicineby Jiangwei Sun of Karolinska Institute, Sweden, and colleagues.

Experimental studies in animals have suggested that infection plays a role in the development of some neurodegenerative diseases, but supporting evidence in humans is limited. In the new study, researchers used data on people diagnosed with AD, PD or ALS from 1970-2016 in Sweden, as well as five matched controls per case, all identified from the Swedish National Patient Register. The analysis included 291,941 AD cases, 103,919 PD cases and 10,161 ALS cases.

A hospital-treated infection 5 or more years before diagnosis was associated with a 16% higher risk of AD (95%CI: 1.15-1.18, P < 0.001) and a 4% higher risk of PD (95%CI: 1.02-1.06, P < 0.001), with similar risks seen for bacterial, viral and other infections and for different sites of infection. The highest risk of disease was seen in people with multiple hospital-treated infections before the age of 40, with more than double the risk of AD (OR=2.62, 95%CI: 2.52-2.72, P < 0.001) and more than 40% increase in the risk of PD (OR=1.41, 95%CI: 1.29-1.53, 3 44 P < 0.001). No association was observed for ALS, regardless of age at diagnosis.

"These findings suggest that infectious events may be a trigger or amplifier of a pre-existing disease process, leading to clinical onset of neurodegenerative disease at a relatively early age," the authors say, while also pointing out that "due to the observational nature of the study, these results do not formally prove a causal link."

Sun adds, "Hospital-treated infections, especially in early- and mid-life, were associated with an increased risk of Alzheimer's disease (AD) and Parkinson's disease (PD), primarily among AD and PD cases diagnosed before 60 years."

advertisement

Story Source:

Materials provided byPLOS.注意:内容可能被编辑风格d length.


Journal Reference:

  1. Jiangwei Sun, Jonas F. Ludvigsson, Caroline Ingre, Fredrik Piehl, Karin Wirdefeldt, Ulrika Zagai, Weimin Ye, Fang Fang.Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.PLOS Medicine, 2022; 19 (9): e1004092 DOI:10.1371/journal.pmed.1004092

Cite This Page:

PLOS. "Repeated infections associated with increased risk of some neurodegenerative diseases: People with hospital-treated infections in early- and mid-life had the greatest risk of Alzheimer's and Parkinson's diseases later in life." ScienceDaily. ScienceDaily, 15 September 2022. /releases/2022/09/220915142440.htm>.
PLOS. (2022, September 15). Repeated infections associated with increased risk of some neurodegenerative diseases: People with hospital-treated infections in early- and mid-life had the greatest risk of Alzheimer's and Parkinson's diseases later in life.ScienceDaily. Retrieved September 6, 2023 from www.koonmotors.com/releases/2022/09/220915142440.htm
PLOS. "Repeated infections associated with increased risk of some neurodegenerative diseases: People with hospital-treated infections in early- and mid-life had the greatest risk of Alzheimer's and Parkinson's diseases later in life." ScienceDaily. www.koonmotors.com/releases/2022/09/220915142440.htm (accessed September 6, 2023).

Explore More
from ScienceDaily

RELATED STORIES